GlassScriptPhysician profile
Christopher S Song
NPI 1770568818
$957.29
in general payments reported to CMS, 2019-2025
18 companies · $270 in 2025
The $270 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $28.52 · 2020: $75.25 · 2021: $73.96 · 2022: $253 · 2023: $99.67 · 2024: $157 · 2025: $270.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $527.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $526.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $120.02 | 2022-2023 | Lokelma |
| Glaxosmithkline, LLC. | $110.61 | 2022-2025 | Nucala |
| Optinose US, INC. | $90.16 | 2020-2024 | |
| Regeneron Healthcare Solutions, INC. | $77.11 | 2020-2022 | |
| Genzyme Corporation | $71.56 | 2025 | |
| Alk-Abello, INC | $70.72 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $68.72 | 2025 | |
| Hikma Pharmaceuticals USA | $50.50 | 2024 | Ryaltris |
| Kaleo, INC. | $49.70 | 2022 | |
| Amgen INC. | $48.79 | 2024 | Repatha |
| Stryker Corporation | $48.55 | 2022 | |
| Genentech USA, INC. | $45.15 | 2025 | Xolair |
| Integra Lifesciences Corporation | $29.95 | 2025 | Trudi Probe, Relieva Spinplus Nav, Inspira Air |
| Horizon Therapeutics Plc | $22.52 | 2022 | |
| Pfizer INC. | $18.94 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cranial Technologies, INC | $17.84 | 2024 | Doc Band |
| Phadia US INC. | $16.45 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Song listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.